Sanjay Basu on affordable T2D medicine in LMICs

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet...

Om Podcasten

Editors at The Lancet Diabetes & Endocrinology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from thyroid cancer to childhood obesity, the mechanisms of ageing to erectile dysfunction, and more.